STC-15

4 Cited Publications
Kundenbewertung

Based on 4 publication(s) in Google Scholar

STC-15 is an orally active RNA methyltransferase METTL3 inhibitor with the activity of activating anti-tumor immunity and reshaping the tumor microenvironment. STC-15 inhibits tumor growth by activating anti-cancer immune responses associated with increased interferon signaling and synergizes with T-cell checkpoint blockade. STC-15 can be used in the study of proliferative diseases such as cancer and autoimmune diseases.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.90%
  • CAS. Nr.: 2648257-56-9
  • Formel: C24H25N5O2
  • Molecular Weight:415.49
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Price: USD 0.00